TrialInvestigational new drugs2013

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies.

Glen J Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.